Literature DB >> 7857506

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.

H Woelk1, G Burkard, J Grünwald.   

Abstract

Effectiveness and acceptance of a 4-week treatment with hypericum extract LI 160 were investigated by 663 private practitioners. The results of the 3250 patients (76% women and 24% men), were recorded using data sheets. The age of the patients ranged from 20 to 90 years (mean 51 years). Of the patients, 49% were mildly depressed, 46% intermediate, and 3% severely depressed. In about 30% of the patients, the situation normalized or improved during the therapy. Undesired drug effects were reported in 79 (2.4%) patients and 48 (1.5%) discontinued the therapy. Most frequently noted side effects were gastrointestinal irritations (0.6%), allergic reactions (0.5%), tiredness (0.4%), and restlessness (0.3%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857506     DOI: 10.1177/089198879400700110

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  11 in total

1.  Taking St John's wort during pregnancy.

Authors:  Ran D Goldman; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-01       Impact factor: 3.275

Review 2.  St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Authors:  L Henderson; Q Y Yue; C Bergquist; B Gerden; P Arlett
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

3.  St John's wort as an antidepressant.

Authors:  P A De Smet; W A Nolen
Journal:  BMJ       Date:  1996-08-03

4.  Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.

Authors:  Changcheng Zhou; Michelle M Tabb; Asal Sadatrafiei; Felix Grün; Aixu Sun; Bruce Blumberg
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

5.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

6.  Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.

Authors:  S Kasper; A Dienel; M Kieser
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

Review 7.  'Atypical' antidepressants in overdose: clinical considerations with respect to safety.

Authors:  Nicholas A Buckley; Thomas A Faunce
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  An Ethnobotanical Study of Medicinal Plants in the Greek Islands of North Aegean Region.

Authors:  Evangelos Axiotis; Maria Halabalaki; Leandros A Skaltsounis
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

Review 9.  Clinical relevance of St. John's wort drug interactions revisited.

Authors:  Simon Nicolussi; Jürgen Drewe; Veronika Butterweck; Henriette E Meyer Zu Schwabedissen
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 10.  Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer's Disease and Brain Ischemia.

Authors:  Veronika Prikhodko; Daria Chernyuk; Yurii Sysoev; Nikita Zernov; Sergey Okovityi; Elena Popugaeva
Journal:  Cells       Date:  2020-10-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.